MedPath

Visual Function With Bilateral AcrySof® ReSTOR® Aspheric SN6AD1

Phase 4
Completed
Conditions
Cataract
Interventions
Device: AcrySof ReSTOR Aspheric IOL model SN6AD1
Registration Number
NCT00710931
Lead Sponsor
Alcon Research
Brief Summary

The objective of this study is to prospectively evaluate the visual parameters in a series of patients after phacoemulsification cataract surgery in a series of patients bilaterally implanted with the AcrySof® ReSTOR® Aspheric +3.0 Intraocular Lens (IOL).

Detailed Description

Not available

Recruitment & Eligibility

Status
COMPLETED
Sex
All
Target Recruitment
35
Inclusion Criteria
  • Prospective subjects should be 21 years of age and older, be of any race and gender and meet study entry criteria. Subject must require extraction of cataracts followed by implantation of a posterior chamber intraocular lens (IOL). Subjects must be candidates for bilateral removal of the natural crystalline lens followed by implantation of a multifocal IOL and be willing and able to complete all follow-up visits.
Exclusion Criteria
  • Subjects with pre-existing conditions that could skew the results or are contraindications for the AcrySof® ReSTOR® IOL should be excluded from the study. Please consult the AcrySof® ReSTOR® Aspheric product inserts under "Precautions" for subject groups that should be excluded from this study.

All subjects must have ≤ 0.75 diopters of astigmatism preoperatively as measured by Keratometry (K) readings. If the surgeon determines that a correction of cylinder is necessary postoperatively, this may be performed after the three month evaluations are completed.

Study & Design

Study Type
INTERVENTIONAL
Study Design
SINGLE_GROUP
Arm && Interventions
GroupInterventionDescription
ReSTOR +3 Multifocal LensAcrySof ReSTOR Aspheric IOL model SN6AD1Bilateral implantation of the AcrySof ReSTOR +3 Intraocular Lens (IOL)
Primary Outcome Measures
NameTimeMethod
Binocular Visual Acuity at Distance, Near and Intermediate6 months after surgery

Uncorrected and best corrected visual acuity (VA) was tested at 4 meters (m), 60 centimeters (cm), and near at preferred distance (distance chosen by each subject and recorded in cm; mean and standard deviation calculated) with a standard ETDRS chart for distance and a hand held chart for near. VA is measured in logMAR. LogMAR is the "logarithm of the minimum angle of resolution". A lower logMAR value indicates better VA.

Secondary Outcome Measures
NameTimeMethod

Trial Locations

Locations (1)

Contact Alcon Call Center for Trial Locations

🇺🇸

Fort Worth, Texas, United States

© Copyright 2025. All Rights Reserved by MedPath